BRAINSTORM CELL THERAPEUTICS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $9.9M | $547.0K |
| FY2017 | — | $5.9M | $2.5M |
| FY2018 | — | $5.0M | $942.0K |
| FY2019 | — | $-12.2M | $536.0K |
| FY2020 | — | $35.5M | $37.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $9.9M | $547.0K |
| FY2017 | — | $5.9M | $2.5M |
| FY2018 | — | $5.0M | $942.0K |
| FY2019 | — | $-12.2M | $536.0K |
| FY2020 | — | $35.5M | $37.8M |